The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Taveras Arthur since 2023.
This trader's CIK number is 1830901.
At the time of last reporting, Taveras Arthur was the Chief Scientific Officer of X4 Pharmaceuticals, Inc. (stock ticker symbol XFOR).
Also see all insider trading activities at X4 Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | XFOR | 0 | $0 | 91,942 | $56,652 | 0 | $0 |
| 2023 | XFOR | 0 | $0 | 85,429 | $64,397 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-07 | XFOR | Sale | 76,920 | .56 | 43,305 |
| 2024-03-11 | XFOR | Sale | 14,235 | .88 | 12,555 |
| 2024-02-12 | XFOR | Sale | 787 | 1.01 | 792 |
| 2023-11-01 | XFOR | Sale | 67,695 | .73 | 49,417 |
| 2023-03-10 | XFOR | Sale | 16,806 | .84 | 14,117 |
| 2023-02-13 | XFOR | Sale | 928 | .93 | 863 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Taveras Arthur (Chief Scientific Officer of X4 Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.